PR_Cls

Press releases

Here you find press releases published by CLS Americas. Press releases for CLS AB are found on our global website here.

CLS Americas Selects Quest International to Provide Aftermarket Service and Logistics Operations for TRANBERG Laser Ablation System, November 21, 2023
CLS Americas States KASRAEIAN Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation, November 9, 2023
CLS Americas and HALO Diagnostics Initiate Prostate Cancer Clinical Study using TRANBERG Focal Laser Ablation System, November 7, 2023
CLS Americas Announces Kearney Urology Center will use its TRANBERG Laser to Provide Focal Laser Ablation Treatments to Prostate Cancer Patients, October 24, 2023
CLS Americas Debuts Mobile Service Program for Office-Based Focal Laser Ablation at Western Section AUA Meeting, October 3, 2023
CLS Americas Presents its TRANBERG™ System for Image-Guided Focal Laser Ablation at Focal Therapy Society 2023 Conference, September 7, 2023
CLS Americas and Focalyx Co-Marketing Agreement for Image-Guided Focal Laser Ablation of Prostate Tumors Using TRANBERG and Focalyx Fusion Systems, August 25, 2023
CLS Americas Announces the National Institutes of Health Clinical Center Placed its 1st Order of the TRANBERG™ Thermal Therapy System for its Research Study - MRI/Ultrasound Fusion-Guided FLA of Prostate Tissue and Prostate Cancer, June 1, 2023
CLS Americas Announces AVANT Concierge Urology has Treated its First Prostate Cancer Patients using the TRANBERG™ Thermal Therapy System, May 11, 2023
CLS Americas and Unio Health Partners Announce Clinical Study “Micro Ultra-Sound Guided Focal Laser Ablation of Low to Intermediate Risk Prostate Cancer”, April 25, 2023
CLS Americas Announces Agreement with AVANT Concierge Urology to Treat Prostate Cancer Patients with TRANBERG™ Thermal Therapy System, April 19, 2023
CLS Americas Announces Research Collaboration with the National Institutes of Health Clinical Center, April 13, 2023
CLS Americas and HALO Diagnostics Announce 25 Patient Study, February 8, 2023
CLS Americas and URN Announce Treatment of Final Patient in Clinical Study, “Targeted MRI/US Fusion Transperineal FLA, January 31, 2023
CLS Americas Exhibits TRANBERG Fusion-Guided FLA at WUSA, November 1, 2022
CLS Americas Presents Fusion-Guided FLA Solution at Unio Health Partner Summit, October 7, 2022
CLS Americas & Focalyx Exhibit at FOCAL Conference, September 23, 2022
CLS Exhibits Fusion-Guided FLA Solution at AUA 2022 Conference, May 12, 2022
CLS and URN Announce First Patient Treated in Clinical Study for Targeted FLA of Low-to-Intermediate Risk Prostate Cancer, April 20, 2022
CLS Americas & URN Announce New 20 Patient Clinical Study, Fusion-Guided FLA, March 29, 2022
CLS Americas Names Michael Magnani President, January 3, 2022
CLS Americas Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors, October 25, 2021
CLS and University Hospital Magdeburg Begin Study of MRI US Fusion-Guided FLA of Prostate Cancer, July 7, 2021
CLS Americas Opens New Offices in Irvine, CA, January 14, 2021
CLS Receives New CPT Code by AMA for Fusion-Guided FLA of Prostate Cancer, November 4, 2020

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!


Please choose your country or region

Global
US